Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

CFO Robert E. Hoffman to deliver company presentation on October 21, 2025 VANCOUVER, Washington, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a ...

Leap Therapeutics ( ($LPTX) ) has shared an update. On October 6, 2025, Leap Therapeutics entered into a Securities Purchase Agreement for a ...

In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

Researchers have discovered the antibody 04_A06, which neutralizes the human immunodeficiency virus (HIV) in almost all ...

Merck, known as MSD outside of the United States and Canada, announced it has initiated three phase 2b trials evaluating the safety and efficacy of tulisokibart (MK-7240), an investigational humanized ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials ...